Hutchmed Agrees to Dispose 35% of Subsidiary to GP Health Service Capital

MT Newswires Live
2025/03/04

Hutchmed (China) (HKG:0013) agreed to dispose of its 35% equity in Shanghai Hutchison Pharmaceuticals or SHPL to two entities under GP Health Service Capital for 3.48 billion yuan, according to a Hong Kong Stock Exchange filing on Monday.

Shanghai GP Zhicheng Private Equity Investment Fund Partnership (Limited Partnership) will acquire 25.1% and Shanghai GP Zhibaihe Enterprise Management Partnership (Limited Partnership) will buy 9.9% of SHPL for 2.50 billion yuan and 982.6 million yuan, respectively.

Shanghai Pharmaceuticals (HKG:2607, SHA:601607) agreed in January to takeover 10% of SHPL, the pharmaceutical company said.

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10